• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

防腐剂、抗氧化剂和增粘剂对酮咯酸氨丁三醇体外角膜渗透的影响。

Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.

作者信息

Malhotra Manjusha, Majumdar D K

机构信息

Department of Pharmaceutics, College of Pharmacy ( University of Delhi ), Pushp Vihar, Sector-III, New Delhi 110 017, India.

出版信息

Indian J Exp Biol. 2002 May;40(5):555-9.

PMID:12622201
Abstract

The influence of formulation additives, e.g. preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine from 0.5%(w/v) aqueous drop was studied using goat cornea. Permeation characteristics of drug, from selected formulations, through excised rabbit cornea were also evaluated. Aqueous solution of ketorolac tromethamine (0.5% w/v), pH 6.5 or 7.0 having ionic strength 0.2, was prepared. To this solution perservatives either alone or in combination with other additives were added to have drops of various composition. Permeation studies with goat cornea showed maximum permeation of ketorolac tromethamine from formulation containing benzalkonium chloride and disodium edetate. Increase in viscosity of drop resulted in decreased permeation of drug. Formulation containing benzalkonium chloride and disodium edetate also increased permeation of drug through rabbit cornea. Cumulative permeation of drug through rabbit cornea was found to be 2.3-2.4 fold higher than that observed with goat cornea.

摘要

采用山羊角膜研究了制剂添加剂(如防腐剂、抗氧化剂和增粘剂)对0.5%(w/v)酮咯酸氨丁三醇滴眼液体外角膜透过性的影响。还评估了选定制剂中药物通过离体兔角膜的渗透特性。制备了pH值为6.5或7.0、离子强度为0.2的酮咯酸氨丁三醇水溶液(0.5% w/v)。向该溶液中单独或与其他添加剂组合添加防腐剂,以制成不同成分的滴眼液。用山羊角膜进行的渗透研究表明,含苯扎氯铵和依地酸二钠的制剂中酮咯酸氨丁三醇的渗透率最高。滴眼液粘度增加导致药物渗透率降低。含苯扎氯铵和依地酸二钠的制剂也增加了药物通过兔角膜的渗透率。发现药物通过兔角膜的累积渗透率比山羊角膜高2.3 - 2.4倍。

相似文献

1
Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.防腐剂、抗氧化剂和增粘剂对酮咯酸氨丁三醇体外角膜渗透的影响。
Indian J Exp Biol. 2002 May;40(5):555-9.
2
In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops.酮咯酸氨丁三醇在缓冲和未缓冲水性滴眼液中的体外角膜透过性。
Indian J Exp Biol. 1997 Sep;35(9):941-7.
3
In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.酮咯酸从油基滴眼液和眼膏的体外角膜渗透情况。
Indian J Exp Biol. 1997 Dec;35(12):1324-30.
4
Effect of concentration, pH, and preservative on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops.浓度、pH值和防腐剂对布洛芬和氟比洛芬从非缓冲水性滴眼液中的体外角膜渗透的影响。
Indian J Exp Biol. 1997 Aug;35(8):844-9.
5
Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.制剂因素对莫西沙星滴眼液经离体山羊、绵羊和水牛角膜体外渗透的影响。
AAPS PharmSciTech. 2006 Feb 10;7(1):E13. doi: 10.1208/pt070113.
6
Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops.制剂因素对加替沙星滴眼液体外角膜透过性的影响。
AAPS PharmSciTech. 2006 Jul 7;7(3):57. doi: 10.1208/pt070357.
7
Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.酮咯酸氨丁三醇透皮凝胶:研发、体外及体内评价
J Pain Palliat Care Pharmacother. 2009;23(1):26-34. doi: 10.1080/15360280902728062.
8
Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.苯扎氯铵/乙二胺四乙酸对兔正常角膜和去上皮角膜滴入酮咯酸氨丁三醇后眼部生物利用度的影响。
J Pharm Sci. 1996 Apr;85(4):415-8. doi: 10.1021/js9504189.
9
Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea.壳聚糖、苯扎氯铵和乙二胺四乙酸对阿昔洛韦透过离体兔角膜的影响。
Int J Pharm. 2008 Feb 4;348(1-2):175-8. doi: 10.1016/j.ijpharm.2007.08.017. Epub 2007 Aug 19.
10
Effect of formulation factors on in-vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea.制剂因素对双氯芬酸从实验性和市售水性滴眼液透过离体山羊角膜的体外渗透的影响。
Yakugaku Zasshi. 2006 Dec;126(12):1369-75. doi: 10.1248/yakushi.126.1369.

引用本文的文献

1
Topical Ocular Drug Delivery: The Impact of Permeation Enhancers.眼部局部给药:渗透促进剂的影响
Pharmaceutics. 2025 Mar 31;17(4):447. doi: 10.3390/pharmaceutics17040447.
2
Whole-Eye Perfusion Model for Screening of the Ocular Formulations via Confocal Laser Scanning Microscopy.基于共聚焦激光扫描显微镜的全眼球灌注模型用于眼部制剂的筛选。
AAPS PharmSciTech. 2019 Sep 12;20(7):307. doi: 10.1208/s12249-019-1493-x.
3
In vitro and ex vivo corneal penetration and absorption models.体外和离体角膜渗透与吸收模型。
Drug Deliv Transl Res. 2016 Dec;6(6):634-647. doi: 10.1007/s13346-015-0275-6.
4
Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis.伏立康唑滴眼液治疗真菌性角膜炎的设计与评价
J Pharm (Cairo). 2014;2014:490595. doi: 10.1155/2014/490595. Epub 2014 Apr 29.
5
Ocular pharmacokinetics of 0.45% ketorolac tromethamine.0.45% 酮咯酸氨丁三醇的眼药代动力学
Clin Ophthalmol. 2010 Dec 1;4:1403-8. doi: 10.2147/OPTH.S15146.
6
Topical ocular delivery of NSAIDs.非甾体抗炎药的眼部局部给药。
AAPS J. 2008 Jun;10(2):229-41. doi: 10.1208/s12248-008-9024-9. Epub 2008 Apr 25.
7
Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.酮咯酸的水性、油性和软膏制剂:对前列腺素E2诱导的眼部炎症的疗效及安全性:技术说明
AAPS PharmSciTech. 2006;7(4):96. doi: 10.1208/pt070496.
8
In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.向兔正常角膜滴注水性、油性和软膏剂剂型后酮咯酸的体内眼内可用性:技术说明
AAPS PharmSciTech. 2005 Oct 24;6(3):E523-6. doi: 10.1208/pt060365.